| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Administration of first dose of tetanus vaccine |
Direct substance |
False |
Tetanus toxoid |
Inferred relationship |
Some |
1 |
| Administration of second dose of tetanus vaccine |
Direct substance |
False |
Tetanus toxoid |
Inferred relationship |
Some |
1 |
| Administration of third dose of tetanus vaccine |
Direct substance |
False |
Tetanus toxoid |
Inferred relationship |
Some |
1 |
| Administration of booster dose of tetanus vaccine |
Direct substance |
False |
Tetanus toxoid |
Inferred relationship |
Some |
1 |
| Administration of final dose of vaccine product containing only Clostridium tetani antigen (procedure) |
Direct substance |
False |
Tetanus toxoid |
Inferred relationship |
Some |
1 |
| Equine rhinopneumonitis - influenza vaccine - tetanus toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Intramuscular injection of human tetanus immunoglobulin |
Direct substance |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Adsorbed diphtheria+tetanus vaccine injection suspension 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Adsorbed diphtheria+tetanus vaccine(for adults and adolescents) injection suspension 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Adsorbed diphtheria+tetanus vaccine(for adults and adolescents) injection suspension 0.5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Adsorbed diphtheria+tetanus vaccine(for adults and adolescents) injection suspension 0.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Tetanus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Adsorbed tetanus vaccine injection solution prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Haemophilus influenzae Type b (Hib)/diphtheria/tetanus/pertussis vaccine vial+prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Haemophilus influenzae Type b (Hib)/diphtheria/tetanus/pertussis vaccine prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Haemophilus influenzae Type b (Hib)/diphtheria/tetanus/pertussis vaccine vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Adsorbed diphtheria+tetanus vaccine injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Adsorbed tetanus vaccine injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria + tetanus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Vaccine product containing whole cell Bordetella pertussis and Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria and tetanus toxoids and acellular pertussis |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Administration of tetanus vaccine |
Direct substance |
False |
Tetanus toxoid |
Inferred relationship |
Some |
1 |
| Tetanus antitoxin, animal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Tetanus toxoid, human |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Encephalomyelitis - influenza vaccine - tetanus toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria and tetanus toxoids with pertussis, combined vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Vaccine product containing Clostridium tetani toxoid antigen adsorbed (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Tetanus and diphtheria toxoid adsorbed for adult use |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Equine influenza vaccine - tetanus toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Vaccine product containing Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Clostridium perfringens type D - tetanus toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Tetanus toxoid, animal |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Encephalomyelitis vaccine - tetanus toxoid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Tetanus vaccination NOS |
Direct substance |
False |
Tetanus toxoid |
Inferred relationship |
Some |
1 |
| Tetanus toxoid, adsorbed 20u/mL 0.5mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 0.6ml/0.5ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria and tetanus toxoid + haemophilus b conjugate vaccine 7.5ml/5ml (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria and tetanus toxoid 0.5vial/haemophilus b conjugate injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria toxoid adsorbed ns/pertussis adsorbed ns/tetanus toxoid adsorbed ns injection suspension vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Adsorbed diphtheria+tetanus+pertussis vaccine injection 7.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Tetanus toxoid, adsorbed 10unt intramuscular injection suspension 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Tetanus toxoid, adsorbed 10unt intramuscular injection suspension 0.5mL syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Adsorbed diphtheria+tetanus+pertussis vaccine injection 0.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Tetanus toxoid fluid |
Is a |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Tetanus and diphtheria toxoid |
Is a |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria + pertussis + tetanus + Haemophilus influenzae type b vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria/tetanus/inactivated poliomyelitis vaccine 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria + tetanus + poliomyelitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria + tetanus + inactivated poliovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria + tetanus + pertussis + poliomyelitis vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria + tetanus + pertussis + inactivated poliovirus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria/tetanus/pertussis/inactivated poliomyelitis vaccine 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria + tetanus + pertussis + poliomyelitis + haemophilus influenzae b vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria/tetanus/pertussis/poliomyelitis/Haemophilus influenzae b vaccine 0.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Vaccine product containing whole cell Bordetella pertussis and Clostridium tetani toxoid adsorbed and Corynebacterium diphtheriae toxoid antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria (low dose)/ tetanus/pertussis/inactivated poliomyelitis vaccine 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria (high dose)/ tetanus/pertussis/inactivated poliomyelitis vaccine 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Tetanus toxoid/reduced diphtheria toxoid/acellular pertussis vaccine injection 0.5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria + pertussis + tetanus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Recombinant hepatitis B virus surface antigen 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis 25micrograms injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25micrograms injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Haemophilus influenzae Type b + tetanus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Haemophilus b polysaccharide + tetanus toxoid 10mcg/24mcg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Haemophilus b polysaccharide 10micrograms/tetanus toxoid 30micrograms powder for injection solution vial + diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Haemophilus influenzae type b 10micrograms/diphtheria toxoid 30 iu/tetanus toxoid 40 iu/pertussis 25micrograms/recombinant hepatitis B virus surface antigen 10micrograms/inactivated poliomyelitis injection solution 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria + tetanus + pertussis + recombinant hepatitis B virus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria + tetanus + pertussis + poliomyelitis + recombinant hepatitis B virus vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria + tetanus + pertussis + poliomyelitis + recombinant hepatitis B virus + recombinant haemophilus influenzae type B vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria toxoid 30 iu/tetanus toxoid 40 iu/acellular pertussis toxoid 25 micrograms/inactivated poliomyelitis 0.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
| Diphtheria + tetanus + haemophilus influenzae type b vaccine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetanus toxoid |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]